Intranasal midazolam for procedural distress in children in the emergency department: a systematic review and meta-analysis.
Jie Yi WangKathy SpeechleyKelly K AndersonGeorge GainhamSamina AliEvelyn D TrottierVikram SabhaneyAnna HeathChristy SichArielle ForbesNaveen PoonaiPublished in: CJEM (2024)
There is limited methodologically rigorous evidence that IN midazolam is better than placebo for IV insertion and laceration repair. At the doses studied, preliminary evidence suggests that IN dexmedetomidine may be superior to IN midazolam for both IV insertion and laceration repair.